3E Bioventures Capital Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 5
- Investments
- 87
- Portfolio
- 55
- Exits
- 17
3E Bioventures Capital General Information
Description
Founded in 2015, 3E Bioventures Capital is a venture capital firm based in Menlo Park, California. The firm seeks to invest in companies operating in the cutting-edge life sciences and biomedical technologies.
Contact Information
Website
www.3ebiovc.com
Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 3000 Sand Hill Road, Building 3
- Suite 100
- Menlo Park, CA 94025
- United States
3E Bioventures Capital Investments (87)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| CytoNiche | 03-Mar-2022 | Early Stage VC | 000.00 | Drug Discovery | Generating Revenue | |
| 00000000 | 03-Feb-2022 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | |
| 00000000 | 26-Jan-2022 | 00000 00000 | Diagnostic Equipment | Generating Revenue | ||
| 0000000 | 19-Jan-2022 | 00000 00000 | Drug Discovery | Generating Revenue | ||
| 00000000 000000000 | 18-Jan-2022 | 00000 00000 | 0000 | Drug Discovery | Startup | 00000 000 00.0 |
| 0000000 0000000000 | 31-Dec-2021 | 00000 00000 | 000.00 | Therapeutic Devices | Generating Revenue | |
| 000000000000 | 09-Dec-2021 | 00000 00000 | 000.00 | Drug Discovery | Pre-Clinical Trials | |
| 0000000 | 01-Dec-2021 | 00000 00000 | 0000 | Drug Discovery | Startup | 00000 000 00.0 |
| Novlead | 15-Nov-2021 | Early Stage VC | 000.00 | Therapeutic Devices | Generating Revenue | 00000 000 00.0 |
| Neural Galaxy | 30-Aug-2021 | Early Stage VC | 000.00 | Diagnostic Equipment | Generating Revenue | 00000 000 00.0 |
3E Bioventures Capital Exits (17)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Cognition Therapeutics | 08-Oct-2021 | IPO | 000.00 |
| 00000 | 23-Jul-2021 | 000 | 00000 |
| 0000000000 | 01-Dec-2020 | 000000000000000000 | 00000 |
| 00 000000000000 | 02-Oct-2020 | 000 | 00000 |
| 000000 000000000 | 24-Sep-2020 | 000000000000000000 | |
| 000000000 | 29-Jul-2020 | 000 | 00000 |
| 00000 0000000000 | 31-Oct-2018 | 000 | 0000 |
| 0000000 | 15-Oct-2018 | 0000000 000000 | |
| Rainbow Children's Clinic | 22-Sep-2018 | Merger/Acquisition | 000.00 |
| BioChain Institute | 06-Jul-2016 | Merger/Acquisition |
3E Bioventures Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trial3E Bioventures Capital Team (12)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Francine Fang Ph.D | Co-Founding Partner & Managing Partner | 0 | 0 | Beijing, China | |
| Karen Liu Ph.D | Co-Founding Partner & Managing Partner | 00 | 0 | 0 | Beijing, China |
| Joy Yang Ph.D | Venture Partner | Beijing, China | |||
| Frank Yan Ph.D | Partner | 0 | 0 | 0 | Beijing, China |
| Jin Li Ph.D | Partner | 0 | Beijing, China |
3E Bioventures Capital Co-Investors (186)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Northern Light Venture Capital | 4 | 0 |
|
|
|
| Foothill Ventures | 0 | 0 |
|
|
|
| Lilly Asia Ventures | 0 | 0 |
|
|
|
| ShangBay Capital | 0 | 0 |
|
|
|
| Sinopharm Capital | 0 | 0 | 0 |
|
|